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Abstract
Introduction: Fungal infections in the immunocompromised host are fairly common. Of the mycoses, Fusarium
species are an emerging threat. Fusarium infections have been reported in solid organ transplants, with three
reports of the infection in patients who had received renal transplants. To the best of our knowledge, this is the
first case of an isolated cutaneous lesion as the only form of infection.
Case presentation: We report the case of a 45-year-old South Indian man who presented with localized
cutaneous Fusarium infection following a renal transplant.
Conclusion: In an immunocompromised patient, even an innocuous lesion needs to be addressed with the
initiation of prompt treatment.
Introduction
Fusarium species are common soil saprophytes and
plant pathogens. Young and Meyers [1] first reported
Fusarium infection in the late 1970s. Since then, several
species have been recognized to be agents of superficial
infections (keratitis, cutaneous infections, onychomyco-
sis and infection of wounds or burns) in humans [2].
More recently, deep-seated, disseminated infections have
been increasingly described in immunocompromised
patients, especially in neutropenic patients [3,4]. The
prognosis is very poor, and death occurs in up to 70%
of the cases despite antifungal therapy [4]. The Fusar-
ium species most frequently involved in human infec-
tions are Fusarium solani, F. oxysporum and F.
moniliforme.
Case report
A 45-year-old South Indian man underwent a renal allo-
graft transplant for end-stage renal disease. He was admi-
nistered tacrolimus, mycophenolate and prednisolone as
immunosuppressive therapy. On follow-up at six months,
he complained of a small, painless nodule on his right
calf. He had no fever, redness or pruritus. He had no
other opportunistic infection. Clinical examination
revealed a subcutaneous, 2 × 2-cm, firm, violaceous
nodule with normal surrounding skin (Figure 1). He had
no other similar lesions. There was no regional lympha-
denopathy. The rest of the physical examination was nor-
mal. His hemogram was normal, as were his computed
tomographic chest and abdominal ultrasound scans. He
underwent fine-needle aspiration of the nodule, which
was reported to have inflammatory cells and a few fungal
hyphae. He subsequently underwent excision of the
nodule, which was sent for microbiological evaluation.
The finding was reported to be Fusarium solani.
A biopsy sample was cultured for fungi on Sabouraud
dextrose agar without cycloheximide and was incubated
at 25°C in air for four days. It grew whitish-gray cottony
colonies suggestive of Fusarium spp. Successive subcul-
tures performed on potato dextrose agar in the dark
stained with periodic acid-Schiff showed sickle-shaped,
multiseptated macroconidia, and one- to two-celled
microconidia had formed from unbranched phialides,
conidiophores and chlamydospores typical of Fusarium
solani (Figure 2).
Subsequently, species identification was further per-
formed using immunohistochemistry (Figure 3). The
patient was successfully treated with surgical excision of
the lesion followed by four weeks of oral voriconazole
treatment.
Discussion
Fusarium species are ubiquitous and may be found in
the soil and air and on plants. In humans, Fusarium* Correspondence: johnsbanerji2002@yahoo.co.in
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species cause disease that is localized, focally invasive or
disseminated. The pathogen generally affects immuno-
compromised individuals, with infection of immuno-
competent persons being rarely reported. Localized
infection includes septic arthritis, endophthalmitis,
osteomyelitis, cystitis and brain abscess. In these situa-
tions, a relatively good response may be expected fol-
lowing appropriate surgery and oral antifungal therapy.
Disseminated infection occurs when two or more non-
contiguous sites are involved [5]. The skin can be an
important and early clue to diagnosis, since cutaneous
lesions may be observed at an early stage of the disease.
Typical skin lesions may be painful red or violaceous
nodules, the center of which often becomes ulcerated
and covered by a black eschar. The multiple necrotizing
lesions are often observed on the trunk and the extremi-
ties [6].
Our patient had a single, localized nodule that was
treated successfully with surgical excision and antifungal
therapy. He did not have any signs of disseminated
infection. At the last follow-up appointment, he had no
symptoms of any disseminated fungemia. Amphotericin
has been the drug of choice to treat most fungal infec-
tions. The use of azoles, namely, voriconazole, posaco-
nazole and ravuconazole, has also been found to be
promising [7]. As the patient was a renal transplant reci-
pient, we chose to use voriconazole to treat him as it
has shown good response in most zygomycoses.
Conclusion
Opportunistic infections in transplant recipients can be
life-threatening. Fusarium infections are recognized
more often, and unless they are diagnosed and treated
early, they can be a cause of significant morbidity and
mortality.
Figure 1 Nodule on the patient’s right calf.
Figure 2 Periodic acid-Schiff stain-positive spores of Fusarium
solani.
Figure 3 Fusarium solani identified by immunohistochemical
staining.
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Consent
Written, informed consent was obtained from the
patient for publication of this case report and accompa-
nying images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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